Prebiotic Ingredients Market (By Type: Fructo-oligosaccharide, Oligosaccharides that aren't carbohydrate-based, Galacto-oligosaccharides, Oligosaccharides Derived from Starch and Glucose, Insulin, Others By Application: Food and Beverage, Dietary Supplements, Infant formula, Animal Nutrition; By Source: Roots, Grains, Vegetables; By Function: Gut Health, Bone Health, Immunity, Heart Health, Weight Management) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Prebiotic Ingredients Market 

5.1. COVID-19 Landscape: Prebiotic Ingredients Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Prebiotic Ingredients Market, By Type

8.1. Prebiotic Ingredients Market, by Type, 2022-2030

8.1.1. Fructo-oligosaccharide

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Oligosaccharides that aren't carbohydrate-based

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Galacto-oligosaccharides

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Insulin

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Lipid

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Prebiotic Ingredients Market, By Application

9.1. Prebiotic Ingredients Market, by Application, 2022-2030

9.1.1. Food and Beverage

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dietary Supplements

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Infant formula

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Animal Nutrition

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Prebiotic Ingredients Market, By Source 

10.1. Prebiotic Ingredients Market, by Source, 2022-2030

10.1.1. Weight Management

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Grains

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Vegetables

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Prebiotic Ingredients Market, By Function 

11.1. Prebiotic Ingredients Market, by Function, 2022-2030

11.1.1. Gut Health

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Bone Health

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Immunity

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Heart Health

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Weight Management

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Prebiotic Ingredients Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by Source (2017-2030)

12.1.4. Market Revenue and Forecast, by Function (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Source (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Function (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Source (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Function (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by Source (2017-2030)

12.2.4. Market Revenue and Forecast, by Function (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Source (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Function (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Source (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Function (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Source (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Function (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Source (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Function (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by Source (2017-2030)

12.3.4. Market Revenue and Forecast, by Function (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Source (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Function (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Source (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Function (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Source (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Function (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Source (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Function (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by Source (2017-2030)

12.4.4. Market Revenue and Forecast, by Function (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Source (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Function (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Source (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Function (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Source (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Function (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Source (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Function (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by Source (2017-2030)

12.5.4. Market Revenue and Forecast, by Function (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Source (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Function (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Source (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Function (2017-2030)

Chapter 13. Company Profiles

13.1. Cargill, Incorporated

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Jarrow Formulas, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. BENEO GmbH

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Royal Cosun

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Cosucra Groupe Warcoing SA

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Nexira

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Yakult Honsha Co.Ltd.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Prenexus Health

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample